Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
Saved in:
| Date: | 2018 |
|---|---|
| Main Authors: | Ye. V. Horodetska, S. V. Serha, E. O. Stakhovskyi, O. A. Kononenko, O. E. Stakhovskyi, M. V. Pikul, S. V. Demydov, I. A. Kozeretska |
| Format: | Article |
| Language: | English |
| Published: |
2018
|
| Series: | Factors in experimental evolution of organisms |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000957446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Mutation 6174delt in BRCA2 gene in family with tumor pathology aggregation (clinical case)
by: O. V. Paliichuk, et al.
Published: (2015)
by: O. V. Paliichuk, et al.
Published: (2015)
The frequency of BRCA1 mutation 5382INSC among women with breast cancer from three regions of Ukraine
by: Ye. V. Horodetska, et al.
Published: (2015)
by: Ye. V. Horodetska, et al.
Published: (2015)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system
by: Ya. O. Tabaliuk, et al.
Published: (2020)
by: Ya. O. Tabaliuk, et al.
Published: (2020)
FGFR3 R249C (742 C>T) mutation in patients with bladder cancer
by: Ya. M. Mishchuk, et al.
Published: (2016)
by: Ya. M. Mishchuk, et al.
Published: (2016)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia
by: V. V. Bentrad, et al.
Published: (2020)
by: V. V. Bentrad, et al.
Published: (2020)
Association of genetic polymorphism with the mutation status of the BRCA1/2 genes in spontanous breast cancer
by: Polinyk, S.I., et al.
Published: (2017)
by: Polinyk, S.I., et al.
Published: (2017)
Blood and urine polyamine as new diagnostic markers of prostate cancer
by: S. P. Zalietok, et al.
Published: (2019)
by: S. P. Zalietok, et al.
Published: (2019)
Biochemical and cytogenetic indices of peripheral blood lymphocytes in patients with prostate cancer
by: E. A. Domina, et al.
Published: (2018)
by: E. A. Domina, et al.
Published: (2018)
Association of TP53 Arg72Pro polymorphism (rs1042522) with bladder cancer risk in the Ukrainian population
by: Ya. M. Mishchuk, et al.
Published: (2018)
by: Ya. M. Mishchuk, et al.
Published: (2018)
Expression of miRNA-126, -205 and -214 in benign and malignant neoplasms of the prostate gland: possible diagnostic and prognostic significance
by: T. V. Zadvornyi, et al.
Published: (2019)
by: T. V. Zadvornyi, et al.
Published: (2019)
Expression pattern of genes associated with tumor microenvironment in prostate cancer
by: Gerashchenko, G.V., et al.
Published: (2018)
by: Gerashchenko, G.V., et al.
Published: (2018)
ПОШИРЕНІСТЬ ГІПЕРМЕТИЛУВАННЯ ПРОМОТОРНОЇ ДІЛЯНКИ ГЕНІВ BRCA1 ТА BRCA2 В ТКАНИНІ РАКУ МОЛОЧНОЇ ЗАЛОЗИ
by: Lobanova, O.E., et al.
Published: (2023)
by: Lobanova, O.E., et al.
Published: (2023)
Del Gaudio S. On the nature of surzyk: a double perspective
by: V. Britsyn, et al.
Published: (2011)
by: V. Britsyn, et al.
Published: (2011)
New techniques for mutation analysis in some exons of PAH and CFTR gene of men using denaturing gradient gel-electrophoresis
by: O. O. Soloviov, et al.
Published: (2008)
by: O. O. Soloviov, et al.
Published: (2008)
NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)
by: Zadvornyi, T.V., et al.
Published: (2023)
A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach
by: Semko, S., et al.
Published: (2023)
by: Semko, S., et al.
Published: (2023)
Del Gaudio S. On the nature of surzyk: a double perspective
by: Бріцин, В., et al.
Published: (2011)
by: Бріцин, В., et al.
Published: (2011)
Men of the molecules
by: V. O. Chernyshenko
Published: (2020)
by: V. O. Chernyshenko
Published: (2020)
Experience of surgical treatment of patients with BRCA1/2-associated hereditary breast cancer
by: I. M. Motuziuk, et al.
Published: (2019)
by: I. M. Motuziuk, et al.
Published: (2019)
Expression of epithelial-mesenchymal transition-related genes in prostate tumours
by: Gerashchenko, G.V., et al.
Published: (2017)
by: Gerashchenko, G.V., et al.
Published: (2017)
Morpholoogical features of castratoin-resistent prostate cancer
by: L. H. Rosha, et al.
Published: (2018)
by: L. H. Rosha, et al.
Published: (2018)
Survival rates of familial and sporadic prostate cancer patients
by: J. Plonis, et al.
Published: (2015)
by: J. Plonis, et al.
Published: (2015)
Search for genes – potential markers of aggressiveness and metastasis for human prostate cancer
by: E. E. Rozenberh, et al.
Published: (2013)
by: E. E. Rozenberh, et al.
Published: (2013)
Modern algorithm of treatment of patients with prostate cancer with bone metastases
by: O. V. Ponomareva, et al.
Published: (2017)
by: O. V. Ponomareva, et al.
Published: (2017)
Development of gene expression panels to determine prostate cancer
by: G. V. Gerashchenko, et al.
Published: (2019)
by: G. V. Gerashchenko, et al.
Published: (2019)
Precision therapy to target apoptosis in prostate cancer
by: G. Kulik
Published: (2014)
by: G. Kulik
Published: (2014)
The effect of metabolic syndrome on prostatic cancer development
by: T. A. Nalbandjan
Published: (2016)
by: T. A. Nalbandjan
Published: (2016)
Non-standard case of cancer of prostate gland (clinical case)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
Internal homonegativity among men having sex with men: a comparative cross-national study
by: O. Shestakovskyi, et al.
Published: (2019)
by: O. Shestakovskyi, et al.
Published: (2019)
Internal homonegativity among men having sex with men: a comparative cross-national study
by: O. Shestakovskyi, et al.
Published: (2019)
by: O. Shestakovskyi, et al.
Published: (2019)
Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
by: V. I. Kiselev, et al.
Published: (2014)
by: V. I. Kiselev, et al.
Published: (2014)
XRCC1 codon 399 polymorphism (RS25487) in the Ukrainian population
by: Ya. M. Mishchuk, et al.
Published: (2017)
by: Ya. M. Mishchuk, et al.
Published: (2017)
Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020)
by: F. Ali, et al.
Published: (2020)
Implication of protocadherin-PC in the progression of the advanced prostate cancer
by: Giannakopoulos, X., et al.
Published: (2007)
by: Giannakopoulos, X., et al.
Published: (2007)
Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: O. A. Chernichenko, et al.
Published: (2014)
by: O. A. Chernichenko, et al.
Published: (2014)
Molecular profiling of prostate tumors
by: H. V. Herashchenko, et al.
Published: (2018)
by: H. V. Herashchenko, et al.
Published: (2018)
Content of metallothionein in the prostate gland tissue of the senior age patients with bleaching hyperplasia and prostate carcinoma
by: O. H. Pykhtieieva, et al.
Published: (2018)
by: O. H. Pykhtieieva, et al.
Published: (2018)
Impact of metabolic syndrome on development of castration-resistant prostate cancer
by: Ju. A. Vinnik, et al.
Published: (2017)
by: Ju. A. Vinnik, et al.
Published: (2017)
Similar Items
-
Mutation 6174delt in BRCA2 gene in family with tumor pathology aggregation (clinical case)
by: O. V. Paliichuk, et al.
Published: (2015) -
The frequency of BRCA1 mutation 5382INSC among women with breast cancer from three regions of Ukraine
by: Ye. V. Horodetska, et al.
Published: (2015) -
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016) -
Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system
by: Ya. O. Tabaliuk, et al.
Published: (2020) -
FGFR3 R249C (742 C>T) mutation in patients with bladder cancer
by: Ya. M. Mishchuk, et al.
Published: (2016)